Since the neuropeptide α-MSH has its own immune regulating/anti-inflammatory properties as well as contributing to the mechanism of ocular immune privilege there is a strong potential of using α-MSH as a therapeutic approach to uveitis (111, 112). The gene discussed is STAMBP; the disease is uveitis.